Clinical Trials in Cleveland

Showing 6601-6620 of 15,050 trials

DNA Hypomethylating Agents and Lenalidomide in Elderly Patients With Myeloid Malignancies in the US

NCT02863458

The study aims to comprehensively analyze data from a large and unselected older AML population in the US, both treated and untreated. These data will widen understanding of treatment decisions for the older Acute Myeloid Leukemia (AML) population. Through use of the SEER-Medicare Registry, the effectiveness and impact of HMA treatments as well as the effectiveness of lenalidomide will be studied.

Acute Myeloid LeukemiaMyelodysplastic Syndromes

The Cleveland ClinicStarted Sep 2018

Cleveland, Ohio, United States

COMPLETEDPhase 290 miles

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

NCT00465517

The study will evaluate the effectiveness and safety of an investigational drug-ganaxolone - on partial seizure frequency in adults with epilepsy taking a maximum of 3 antiepileptic medications (AEDs). The study will also evaluate the effectiveness of ganaxolone in females with catamenial epilepsy. Catamenial epilepsy refers to a relationship between seizure frequency and a woman's menstrual cycle, where the number of seizures increases around the time of a woman's menstrual cycle.

Partial EpilepsyCatamenial Epilepsy

Marinus Pharmaceuticals147 participantsStarted Feb 2007

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +24 more locations

DNA Hypomethylating Agents and Lenalidomide in Elderly Patients With Myeloid Malignancies in the US

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

Find Trials by Condition in Cleveland

Transmural Systems Transcaval Closure Device for Transcaval Access Ports During Transcatheter Aortic Valve Replacement

Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma

A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma

A Study to Test if TEV-48574 is Effective in Relieving Asthma

An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy

A Prospective Clinical Study of Phenylketonuria (PKU)

Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension

Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination Thru Engagement in Mindfulness Education

Assessment of Safety and Efficacy of Nerivio for the Migraine Prevention

Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]

AMBULATE Continued Access Protocol to Evaluate the Cardiva Mid-Bore Venous Vascular Closure System (VVCS)

Bioavailability and Bioequivalence of Two Risdiplam Tablets in Healthy Participants

A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease

A PK, Safety and Tolerability Study of Peripheral and Central Infusion of Melflufen in RRMM Patients